The Biomarker: Melanoma

Sanjiv S. Agarwala, MD
Video Categories: The Biomarker

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
July 29, 2015

The Status of the Standard of Care for Cancer Patients

Dr. Alex Adjei discusses how the standard of care for cancer patients has improved overt he last few years, but there is still a great need for new treatments designed to help a broader range of cancer patients.

January 20, 2016

Targeting Resistant Cells

Dr Wainberg and Dr Gerson talk about going after this cell population and some of the findings of myeloid leukemia research.